Abeona Therapeutics Announces European Regulatory Approval for Phase 1/2 Gene Therapy Clinical Study for Patients With Sanfilippo ...
NEW YORK, NY and CLEVELAND, OH--(Marketwired - August 04, 2016) - Abeona Therapeutics, Inc. (NASDAQ: ABEO) Approval of clinical trial for ABO-102 (AAV-SGSH) in European Union marks 3rd regulatory approval for the company, 2nd for ABO-102 Approval following …